Overview

Once Weekly D-cycloserine for Schizophrenia

Status:
Withdrawn

Trial end date:
2011-06-01

Target enrollment:

Participant gender:

Summary

This is a parallel-group, placebo-controlled trial examining the cognitive effects at weeks 1, 4, & 8 of once-weekly oral D-cycloserine 50 mg added to a stable dose of antipsychotic for 8 weeks in adult outpatients with schizophrenia.

Phase:

Phase 4

Details

Lead Sponsor:

Massachusetts General Hospital

Collaborator:

National Institute of Mental Health (NIMH)

Treatments:

Cycloserine